April 18, 2017: Hearing vague takeover rumors circulating about Sarepta Therapeutics. The rumor is that Alexion could be interested in acquiring the company at around $55 per share. Could not find the source of the rumors.
February 14, 2017: Sarepta Therapeutic’s stock has formed a candle over candle reversal after Feuerstein said, “Sarepta Therapeutics is (Read More….)
January 9, 2017: Biotechnology firm PTC Therapeutics’ stock broke above the 200 day MA today as it received notification from the European Commission (EC) of its adoption of a positive decision granting annual renewal of the conditional marketing authorization for Translarna (ataluren). The positive decision is based on the recent renewal recommendation by the Committee (Read More….)